EDCTP-AIGHD Special Session at the Virtual Global Forum

Invitation to the EDCTP-AIGHD Special Session at the Virtual Global Forum on TB Vaccines: Launch of a Global Roadmap


Accelerating TB vaccine research and development: launch of a global roadmap

Tuesday, 20 April 2021 |  18:00-19:30 CEST

The European & Developing Countries Clinical Trials Partnership (EDCTP) has commissioned the Amsterdam Institute for Global Health and Development (AIGHD) to develop a Global TB Vaccine R&D Roadmap to identify priorities to coordinate global action to accelerate the development and implementation of new TB vaccines. The Roadmap has been developed through an iterative global consultative process designed to identify the key barriers to TB vaccine R&D and implementation, and potential ways in which they might be overcome. It is intended to provide a shared set of priorities to guide the activities of all stakeholders with an interest in TB vaccine development and use.

AIGHD and EDCTP are pleased to invite the global TB vaccine community and interested stakeholders to attend the official launch of the Roadmap. This special session hosted by the Virtual Global Forum on TB Vaccines opens with an introduction to the Roadmap, followed by an overview of current challenges and opportunities for TB vaccine R&D, and the perspective from a community representative. The presentations will be followed by a panel discussion with a diverse group of stakeholders, each sharing their comments on the Roadmap, their views on how they are planning to use it, and how they consider it can guide the future development of TB vaccines.



  • Mark Hatherill, South African Tuberculosis Vaccine Initiative (SATVI)
  • Matteo Zignol, Global TB Programme, World Health Organisation (WHO)


  • Frank Cobelens, Amsterdam Institute for Global Health and Development (AIGHD)
  • Willem Hanekom, Africa Health Research Institute (AHRI)
  • Blessina Kumar, Global Coalition of TB Activists (GCTA)
  • Michael Makanga, Executive Director, EDCTP


18:00 – 18:05 Welcome, opening remarks and introduction from the chair(s)

Mark Hatherill, SATVI and Matteo Zignol, WHO

18:05 – 18:15 The TB Vaccine R&D Roadmap: actions and enabling considerations

Frank Cobelens, AIGHD

18:15 – 18:35 Opportunities for TB Vaccine R&D

Willem Hanekom, AHRI

18:35 – 18:45 A community perspective on the TB Vaccine R&D Roadmap

Blessina Kumar, GCTA

18:45 – 18:50 Q&A session


18:50 – 19:20 Feedback from panel

Videlis Nduba (KEMRI), Ann Ginsberg (Gates Foundation), Birgitte Giersing (WHO), Rajinder Suri (DCVMN), Agnès Saint-Raymond (EMA)

19:20 – 19:25 Q&A and feedback from participants


19:25 – 19:30 Next steps and closing remarks

Michael Makanga, EDCTP

Twitter           LinkedIn            Youtube